Kainos Medicine Inc (284620) — Cash Flow Quality Index

Latest as of March 2020: -0.96x

Kainos Medicine Inc (284620) has a Cash Flow Quality Index of -0.96x as of March 2020. Operating cash flow of ₩-21.44 Million is below net income of ₩22.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Kainos Medicine Inc cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.96x
Operating CF / Net Income

Operating Cash Flow

₩-21.44 Million
KRW

Net Income

₩22.37 Million
KRW

Data as of

Mar 2020
Most recent filing

Kainos Medicine Inc Cash Flow Quality Index (2017–2019)

Historical Cash Flow Quality Index for Kainos Medicine Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Kainos Medicine Inc to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Kainos Medicine Inc (2017–2019)

Year-by-year earnings quality comparison for Kainos Medicine Inc. For live market cap and the full company financial profile, see 284620 stock market capitalisation.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2019 7.95x ₩185.74 Million ₩23.36 Million ▲ +242.6%
2018 -5.58x ₩-22.01 Million ₩3.95 Million ▼ -676.7%
2017 -0.72x ₩-27.23 Million ₩37.93 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.